'Muskonomy' shakeup: SpaceX valuation approaches Tesla's after merger with xAI
cnbc.com
Want to monitor HROW?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor HROWHarrow Health, Inc. owns a portfolio of ophthalmic pharmaceutical businesses, including ImprimisRx, the nation's leading ophthalmology outsourcing facility and pharmaceutical compounding business. The company holds large equity positions in Eton Pharmaceuticals, Surface Ophthalmics, and Melt Pharmaceuticals.